Agilent Antibody Featured Content

  1. Complementary Methodologies For Size Heterogeneity Analysis Of Antibody Impurities 6/22/2026

    Combining denaturing and native analytical techniques reveals molecular weight impurities in mAbs, delivering a more complete and reliable purity profile that supports confident decisions.

  2. Best Practices For Protein Analysis With An Analyzer System 6/18/2026

    Strong protein analysis relies on optimized preparation, buffer consistency, and precise method settings. Gain insight into how small changes in temperature, storage, or injection can impact accuracy.

  3. Comparing Two CE-SDS Systems Using NISTmAb 6/18/2026

    Fluorescence and UV detection deliver highly comparable results in protein capillary electrophoresis. See how both approaches perform across systems and what it means for protein analysis.

  4. Accurate mAb Sizing Using The NIST mAb As A Ladder 6/18/2026

    Improve your mAb sizing accuracy by integrating a well-characterized reference standard into your analysis workflows, which reduces variability and delivers more precise measurements.

  5. A New Story For Myoglobin—Producing Yeast-Generated Alternative 3/4/2026

    A fast, automated protein analysis workflow empowers researchers to screen yeast strains more efficiently. See how this streamlined approach accelerates innovation while supporting sustainability.

  6. Analysis Of NIST Antibody On An Analyzer System 3/4/2026

    Explore a detailed comparison of antibody fragment separation methods that shows how advanced electrophoresis systems closely align with established NIST benchmarks, offering clear resolution.

  7. A Comparison Of Sizing And Quantification Performance 2/27/2026

    Explore how automated electrophoretic analysis improves protein QC by delivering sharper sizing accuracy, stronger quantitative linearity, and greater consistency than conventional gel workflows.

  8. Complementary Methodologies For Analysis Of NISTmAb Impurities 2/27/2026

    Gain insight into how SEC and CE‑SDS complement each other to assess monoclonal antibody size variants, offering stronger insight into aggregates, fragments, and overall purity.